Advanced therapy medicinal products: a comprehensive overview for pharmacy professionals

After reading this article, you should be able to:

• Describe the name, type, mechanism of action and landmark clinical trials of licensed advanced therapy medicinal products (ATMPs) currently approved for use in the UK;
• Explore processes for predicting future ATMPs;
• Establish the role of pharmacy professionals, including the chief pharmacist, clinical pharmacy professional and quality assurance specialist in the preparation and administration of ATMPs, and the pharmacy infrastructure needed for ATMPs;
• Describe the patient and product journey for an ATMP, from production to administration, with a focus on chimeric antigen receptor T-cell therapies;
• Depict ATMP regulatory processes;
• Establish the process for assessing cost-effectiveness and reimbursement strategies for ATMPs in the UK.